Ambrisentan Medications

Ambrisentan Info

What is Ambrisentan?

Ambrisentan belongs to a class of medicines called endothelin-receptor antagonists. It works to relax blood vessels, helping to lower pressure in the lungs. In Hong Kong, the active ingredient ambrisentan is available in the prescription product Letairis.

Medications with Ambrisentan

The primary medication that contains ambrisentan is Letairis. It is supplied as oral tablets in two strengths-5 mg and 10 mg. Letairis is marketed under its brand name, but the same active ingredient can also be obtained as a generic version once it becomes available. Both the branded and generic tablets are designed for once-daily use and are listed on the Hong Kong Department of Health’s medication register.

What Does Ambrisentan Treat?

• Pulmonary arterial hypertension (PAH) - a condition where high blood pressure builds up in the arteries that supply the lungs, making breathing difficult and causing fatigue. Ambrisentan helps to lower this pressure, easing symptoms and improving exercise capacity.
• WHO Group 1 PAH - includes idiopathic PAH, hereditary forms, and PAH associated with connective-tissue disease or congenital heart defects. Patients with these specific types may be prescribed ambrisentan as part of a long-term management plan.

These uses reflect the indications approved by Hong Kong’s regulatory authorities. Off-label uses are not discussed here.

How Ambrisentan Works

Ambrisentan blocks the action of endothelin-1, a natural substance that makes blood vessels tighten. By preventing this tightening, the drug allows the pulmonary arteries to relax and widen, which reduces the pressure that the heart must pump against. The effect usually begins within a few days after starting treatment and is maintained with regular daily dosing.

Safety Information

Common Side Effects

• Headache, often mild and temporary.
• Facial flushing or a feeling of warmth.
• Swelling of the ankles or feet (peripheral edema).
• Nasal congestion or a runny nose.
• Mild fatigue.

These reactions are generally short-lived and may improve as the body adjusts to the medication.

Serious Reactions

• Liver concerns - although less frequent than with some similar drugs, signs such as yellowing of the skin or eyes, dark urine, or persistent abdominal discomfort require urgent medical attention.
• Anemia - a drop in red blood cell count that can cause tiredness or shortness of breath.
• Pregnancy risk - ambrisentan is known to cause serious birth defects. Women who are pregnant, may become pregnant, or are breastfeeding must avoid the drug.

If any of these serious signs appear, seek medical help immediately.

Who Should Be Cautious

• Individuals with severe liver impairment.
• Patients who are pregnant, planning pregnancy, or are nursing.
• Persons with a history of allergic reactions to ambrisentan or any component of Letairis.

Interaction Awareness

• Drugs that strongly inhibit the enzyme CYP3A4 (e.g., certain antifungals or macrolide antibiotics) can increase ambrisentan levels and may raise the risk of side effects.
• Combining ambrisentan with other endothelin-receptor antagonists is not recommended.
• Alcohol can enhance dizziness or flushing; moderation is advised.
• Specific food-drug interactions are uncommon, but patients should review any new medication with a pharmacist.

For a complete list of interactions, refer to the product-specific information available with each medication.

What to Know Before Using

Store Letairis tablets at room temperature, away from moisture and direct sunlight. The medication is intended for long-term use under medical supervision, and treatment length may differ between acute and chronic cases. Remember that each product containing ambrisentan may have its own instructions for use. For detailed usage, dosing, and administration, refer to your specific medication’s information.

Key Terms

Pulmonary arterial hypertension (PAH): High blood pressure in the arteries that carry blood from the heart to the lungs.

Endothelin-receptor antagonist: A drug that blocks endothelin-1, a substance that causes blood vessels to narrow.

Peripheral edema: Swelling that occurs in the lower limbs due to fluid buildup.

Information Disclaimer

This article offers general educational information about ambrisentan as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing ambrisentan may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.